Alprazolam Xanax Row Powder CAS 28981-97-7

FOB Price: USD 2500 - 2800
|
0.1 Kilograms (Min. Order)
  • Supplying Ability5000 Kilograms Per Month
  • Supplying TypeIn stock
  • Model Number+86 13716475393
  • Preferred Payment Method:T/T, Western Union, Money Gram

Quick Details

  • purity:99.7%
  • Processing Time:1days
  • Port:Shenzhen,China
  • Supply Ability: 5000 Kilograms Per Month
  • Brand Name:+86 13716475393
Detailed Product Description Product Name:Alprazolam PowderPurity:99% Payment Terms:WU MG T/T CAS:28981-97-7 Appearance:Whtie PowderEINECS:249-349-2 Pure White Alp powders Xanax CAS 28981-97-7 Pure Alprazolam Powders We produce high purity alprazolam powder,Have more than three years, the market throughout the United States, Canada, Australia and many Europeancountries.With regard to its production and transportation, we are very professional. I hope you can try it, and then we establish a long-term relations of cooperation. We only produce alp, no other product, because the single-minded, so professional Looking forward to your contact. alprazolam powder Xanax alprazolam powder Xanax alprazolam powder Xanax alprazolam powder Xanax  Recreational use See also: Benzodiazepine misuse There is a risk of misuse and dependence in both patients and non-medical users of alprazolam; the pharmacological properties of alprazolam such as high affinity binding, high potency, being short-acting and having a rapid onset of action increase the abuse potential of alprazolam. The physical dependence and withdrawal syndrome of alprazolam also adds to the addictive nature of alprazolam. In the small subgroup of individuals who escalate their doses there is usually a history of alcohol or other substance use disorders.Despite this, most prescribed alprazolam users do not use their medication recreationally, and the long-term use of benzodiazepines does not generally correlate with the need for dose escalation.[85] However, based on US findings from the Treatment Episode Data Set (TEDS), an annual compilation of patient characteristics in substance abuse treatment facilities in the United States, admissions due to "primary tranquilizer" (including, but not limited to, benzodiazepine-type) drug use increased 79% from 1992 to 2002, suggesting that misuse of benzodiazepines may be on the rise.The New York Times also reported in 2011 that "The Centers for Disease Control and Prevention last year reported an 89 percent increase in emergency room visits nationwide related to nonmedical benzodiazepine use between 2004 and 2008." Alprazolam is one of the most commonly prescribed and misused benzodiazepines in the United States.A large-scale nationwide U.S. government study conducted by SAMHSA found that, in the U.S., benzodiazepines are recreationall